- Home
- SM vs RXRX Comparison
SM vs RXRX Comparison
Compare SM & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.84
Company Overview
Basic Information| Metric | SM | RXRX |
|---|---|---|
| Founded | 1908 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | 1992 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SM | RXRX |
|---|---|---|
| Price | $18.53 | $4.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $34.14 | $7.50 |
| AVG Volume (30 Days) | 3.1M | ★ 24.1M |
| Earning Date | 02-18-2026 | 02-27-2026 |
| Dividend Yield | ★ 4.40% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.33 | N/A |
| Revenue | ★ $3,166,673,000.00 | $43,689,000.00 |
| Revenue This Year | $31.49 | $6.74 |
| Revenue Next Year | $68.57 | $34.31 |
| P/E Ratio | $2.87 | ★ N/A |
| Revenue Growth | ★ 35.48 | N/A |
| 52 Week Low | $17.45 | $3.79 |
| 52 Week High | $44.95 | $12.36 |
Technical Indicators
Market Signals| Indicator | SM | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.25 | 56.88 |
| Support Level | $17.45 | $4.62 |
| Resistance Level | $18.49 | $4.98 |
| Average True Range (ATR) | 0.71 | 0.21 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 50.93 | 79.23 |
Price Performance
Historical Comparison SM
RXRX
About SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.